Close

Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share

December 27, 2012 4:16 PM EST
Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock and the fully exercised over-allotment option to purchase 480,000 additional shares, offered at a price of $0.95 per share. The gross proceeds to Echo from this offering were approximately $3.5 million, before deducting the underwriting discount and other offering expenses payable by Echo.

Aegis Capital Corp. acted as the sole book-running manager for the offering.

Feltl and Company acted as co-manager for the offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Credit Ratings, Equity Offerings